Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transplacental carcinogens.

A B Barnes

    Comprehensive Therapy
    |March 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Maternal exposure to carcinogens can induce fetal cancer through transplacental transfer. Individual fetal metabolism and genetics influence cancer development, highlighting the complexity of transplacental carcinogenesis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    High-Field Dynamic Nuclear Polarization for Solid and Solution Biological NMR.

    Applied magnetic resonance·2009
    Same author

    A comparison of pregnancy history recall and medical records. Implications for retrospective studies.

    American journal of epidemiology·1985
    Same author

    Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project.

    JAMA·1984
    Same author

    Breast cancer in mothers given diethylstilbestrol in pregnancy.

    The New England journal of medicine·1984
    Same author

    Menstrual history and fecundity of women exposed and unexposed in utero to diethylstilbestrol.

    The Journal of reproductive medicine·1984
    Same author

    Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project.

    American journal of obstetrics and gynecology·1984
    Same journal

    Heparin-induced thrombocytopenia and thrombosis.

    Comprehensive therapy·2011
    Same journal

    Antiplatelet therapy in cardiovascular disease.

    Comprehensive therapy·2011
    Same journal

    Genetics of cardiovascular disease.

    Comprehensive therapy·2011
    Same journal

    Septic renal vein thrombosis complicated by septic pulmonary embolism.

    Comprehensive therapy·2011
    Same journal

    Gout and hyperuricemia.

    Comprehensive therapy·2011
    Same journal

    Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.

    Comprehensive therapy·2010
    See all related articles

    Area of Science:

    • Oncology
    • Developmental Biology
    • Toxicology

    Background:

    • Cancer can metastasize to the placenta and fetus, and can arise in early life without familial predisposition.
    • Chemical carcinogens administered to mothers can induce cancer in the fetus and experimental animals.
    • Many carcinogens also exhibit abortifacient and teratogenic properties.

    Purpose of the Study:

    • To explore the mechanisms by which maternal exposure to carcinogens can lead to fetal cancer.
    • To understand the role of transplacental transfer and fetal factors in carcinogenesis.
    • To provide a foundation for future research into transplacental carcinogens.

    Main Methods:

    • Review of existing literature on transplacental carcinogens.
    • Analysis of metabolic pathways and genetic influences on fetal cancer development.

    Related Experiment Videos

  • Extrapolation of adult carcinogenesis pathways to the fetal context.

    • Main Results:

    • Carcinogens administered to mothers are dispersed through metabolic pathways and transferred transplacentally.
    • Fetal metabolic pathways and genetic makeup significantly influence the expression of carcinogenic potential.
    • Potential carcinogens can act as abortifacients and teratogens, complicating cancer induction.

    Conclusions:

    • Transplacental exposure to carcinogens poses a significant risk for fetal cancer development.
    • Individual fetal factors play a critical role in determining susceptibility to transplacental carcinogenesis.
    • Further research into adult carcinogenesis pathways is essential for understanding and addressing transplacental cancer risks.